This approach has been applied for glioma using an RCAS‐kRas/RCAS‐Akt‐driven astrocytoma model, in which kRas expression is dependent on the administration of doxycycline (35). The gene discussed is AKT1; the disease is astrocytoma (excluding glioblastoma).